Bayer reported EUR129M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Air Liquide EUR 2.89B 48.7M Jun/2026
Akzo Nobel EUR -73M 324M Sep/2026
Alcon AG USD 381M 337M Sep/2026
Amarin USD -2.26M 564K Dec/2025
Arkema EUR 123.3M 64.4M Sep/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
BASF EUR -131M 1.57B Sep/2026
Bayer EUR 129M 698M Sep/2026
Beiersdorf EUR 760M 256M Jun/2026
Corteva USD 43.03B 41.08B Sep/2026
Covestro EUR -324M 5.72B Dec/2025
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 153.27M Sep/2026
Genmab DKK 407M 182M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 394M 65M Sep/2026
Henkel EUR 1.64B 220M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Johnson Matthey GBP 198M 56M Jun/2026
Linde USD 2.55B 172M Sep/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 660M 437M Sep/2026
Novartis USD 5.14B 392M Sep/2026
Nutrien USD 642M 1.21B Sep/2026
Philips EUR 165M 445M Sep/2026
PPG Industries USD 648M 12M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 2.34B Sep/2026
SAP EUR 926M 1.72B Sep/2026
Solvay EUR 75M 2M Sep/2026
UCB EUR 1.29B 571M Dec/2025
Umicore EUR -13.2B 13.91B Jun/2026
Vinci EUR 4.01B 2.04B Jun/2026